Alternative strategies

Carmignac Portfolio Merger Arbitrage Plus

Luxembourg SICAV sub-fundGlobal marketSRI Fund Article 8
Share Class

LU2601234169

An active absolute return strategy focusing on merger arbitrage opportunities
  • An active merger arbitrage strategy that aims to provide positive absolute returns, with limited correlation to equity markets.
  • An alternative strategy with a socially responsible investment approach, focusing on officially announced M&A deals in the developed markets.
  • Strategy offering positive correlation with interest rates.
Risk Indicator

1

2

3

4

5

6

7

Lowest risk Highest risk
Recommended Minimum Investment Horizon
3 years
Cumulative Performance since launch
+ 11.7 %
-
-
-
+ 6.5 %
From 14/04/2023
To 10/06/2025
Calendar Year Performance 2024
-
-
-
-
-
-
-
-
+ 3.8 %
+ 4.5 %
Net Asset Value
111.65 £
Asset Under Management
205 M €
Net Equity Exposure30/05/2025
82.7 %
SFDR - Fund Classification

Article

8
Data as of:  10 Jun 2025.
​Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.

Carmignac Portfolio Merger Arbitrage Plus fund performance

Take a look at the Fund's performance supported by our Fund managers’ market commentary and strategy insight.

Our monthly comments

Data as of:  30 May 2025.
Fund management team

Market environment

• After two turbulent months, May saw a return to calm for the markets and also for merger arbitrage, with most asset classes ending the month in positive territory and the HFRX Merger Arbitrage Index posting a 1.42% gain (in US dollars) over the month.• Overall, merger arbitrage spreads tightened somewhat. Notable examples include the narrowing of Hess ahead of the arbitration between Chevron and Exxon over the Stabroek oil field off the coast of Guyana, and the rise in Covestro, which is making good progress with the various competition authorities. Ansys, still awaiting approval from the Chinese authorities, benefited from the easing of tensions between the US and China. • In addition, just over a dozen transactions were completed, which also contributed to the tightening of spreads. • The notable event of the month was the resumption of M&A activity after a period of uncertainty linked to the trade war launched by the Trump administration. Thirty-two new transactions were announced during the month, compared with only 13 in the previous month. • While activity remains modest in the US, Europe and especially Asia have taken over, accounting for 47% of total new transactions. Japan was particularly active, with not only one significant transaction (the purchase of NTT Data Group by its parent company for $14 billion) but also a large number of smaller deals. • As expected, the fall in interest rates is enabling financial buyers to continue deploying their capital. Private equity groups accounted for nearly 25% of new transactions.

Performance commentary

• The fund posted a positive performance during the month.• The main contributors to performance were: Spartan Resources, Covestro, Ansys. • The main detractors to performance were: Fortnox, Interpublic Group, Juniper Network.

Outlook strategy

• The fund's investment ratio is 105%, up from the previous month.• With 53 positions in the portfolio, diversification remains satisfactory. • 2025 continues to look much more promising than 2024 thanks to a more favourable antitrust environment for M&A activity worldwide: the change of administration in the US following Trump's election, the publication of the Draghi report in Europe recommending the emergence of national champions to face global competition, regulators in the UK being pushed by politicians to prioritise economic activity, and the Japanese market continuing to open up to foreign capital. • Lower interest rates should also drive M&A activity in the coming quarters. • However, instability linked to the trade war launched by the Trump administration and geopolitical tensions are slowing the recovery, which is less robust than we had hoped.

Performance Overview

Data as of:  10 Jun 2025.
​Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). Morningstar Rating™ :  © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
Source: Carmignac at 11/06/2025

Carmignac Portfolio Merger Arbitrage Plus Portfolio overview

Below is an overview of the composition of the portfolio.

Geographical Breakdown

Data as of:  30 May 2025.
North America41.9 %
Others13.7 %
Europe EUR13.6 %
Europe ex-EUR13.4 %
Not Integrated-
View details

Key figures

Below are the key figures for the Fund, which will give you a clearer idea of the Fund's management and equity positioning.

Exposure Data

Data as of:  30 May 2025.
Equity Investment Weight75.8 %
Net Equity Exposure82.7 %
Number of Equity Issuers42

The strategy in a nutshell

Discover the Fund’s main features and benefits through the words of the Fund Managers.
Fund Management Team
The advantage of Merger Arbitrage strategy is that it carries virtually no market risk. The only associated risk is that of a deal failure. That is why our approach is very cautious on two levels: we’re very selective in choosing the deals and we aim to maintain a highly diversified portfolio.
View Fund's characteristics

Related articles

Alternative Strategy14 April 2025English

Carmignac Portfolio Merger Arbitrage Plus: Letter from the Fund Managers

3 minute(s) read
Find out more
Alternative Strategy17 January 2025English

Carmignac Portfolio Merger Arbitrage Plus: Letter from the Fund Managers

2 minute(s) read
Find out more
Alternative Strategy9 October 2024English

Carmignac Portfolio Merger Arbitrage Plus: Letter from the Fund Managers

4 minute(s) read
Find out more
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice.
The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
Carmignac Portfolio is a sub-fund of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive.
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.). The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.